Monma, T.; Iwamoto, J.; Honda, A.; Ueda, H.; Kakizaki, F.; Yara, S.; Miyazaki, T.; Ikegami, T.
Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile. Metabolites 2022, 12, 331.
https://doi.org/10.3390/metabo12040331
AMA Style
Monma T, Iwamoto J, Honda A, Ueda H, Kakizaki F, Yara S, Miyazaki T, Ikegami T.
Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile. Metabolites. 2022; 12(4):331.
https://doi.org/10.3390/metabo12040331
Chicago/Turabian Style
Monma, Tadakuni, Junichi Iwamoto, Akira Honda, Hajime Ueda, Fumio Kakizaki, Shoichiro Yara, Teruo Miyazaki, and Tadashi Ikegami.
2022. "Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile" Metabolites 12, no. 4: 331.
https://doi.org/10.3390/metabo12040331
APA Style
Monma, T., Iwamoto, J., Honda, A., Ueda, H., Kakizaki, F., Yara, S., Miyazaki, T., & Ikegami, T.
(2022). Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile. Metabolites, 12(4), 331.
https://doi.org/10.3390/metabo12040331